2011
DOI: 10.1016/j.neuint.2011.06.021
|View full text |Cite
|
Sign up to set email alerts
|

Effects of a new synthetic butyrylcholinesterase inhibitor, HBU-39, on cell proliferation and neuroblast differentiation in the hippocampal dentate gyrus in a scopolamine-induced amnesia animal model

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
5
0

Year Published

2012
2012
2020
2020

Publication Types

Select...
9

Relationship

2
7

Authors

Journals

citations
Cited by 12 publications
(5 citation statements)
references
References 46 publications
0
5
0
Order By: Relevance
“…Furthermore, AChE inhibitors, such as donepezil hydrochloride, have been shown to enhance neurogenesis via downregulation of AChE activity in mice with vascular dementia [61, 62]. Finally, we have previously demonstrated that inhibition of AChE or butyrylcholinesterase activity significantly increases the cell proliferation and neuroblast differentiation in the dentate gyrus [63]. …”
Section: Discussionmentioning
confidence: 99%
“…Furthermore, AChE inhibitors, such as donepezil hydrochloride, have been shown to enhance neurogenesis via downregulation of AChE activity in mice with vascular dementia [61, 62]. Finally, we have previously demonstrated that inhibition of AChE or butyrylcholinesterase activity significantly increases the cell proliferation and neuroblast differentiation in the dentate gyrus [63]. …”
Section: Discussionmentioning
confidence: 99%
“…After this period, animals were anesthesized using chlorpent (2 ml/kg) and a 0.5 cm incision was made on the abdominal skin. Alzet osmotic pumps (Durect Co., Cupertino, CA) containing 2 ml saline, or 440 mg/ml of SCO solution were subcutaneously embedded in abdominal wall as previously described [32], [33]. SCO release (0.25 µl/h) was maintained for 28 days and administration of LBPs was continued as before throughout SCO treatment.…”
Section: Methodsmentioning
confidence: 99%
“…In fact, the memory impairment produced in rats following intraperitoneal injections of scopolamine resembles the clinical symptoms of AD patients [ 38 ]. Scopolamine influences the expression of several genes associated with muscarinic receptor signaling pathways, apoptosis, and cell differentiation in the rat brain [ 39 ]. The 2VO/H technique aimed to model global cerebral ischemia, which occurs in VD patients and essentially comprises both permanent bilateral CCA occlusion and hypovolemic conditioning.…”
Section: Discussionmentioning
confidence: 99%
“…In fact, the memory impairment produced in rats following intraperitoneal injections of scopolamine resembles the clinical symptoms of AD patients [38]. Scopolamine influences the expression of several genes associated with muscarinic receptor signaling pathways, apoptosis, and cell differentiation in the rat brain [39] nique aimed to model global cerebral ischemia, which occurs in VD patients and essentially comprises both permanent bilateral CCA occlusion and hypovolemic conditioning. This model produces pathophysiologic changes including ischemic neuronal damage, neuroinflammatory changes in the hippocampus, and the impairment of hippocampus-related behaviors such as cognition, spatial learning, and memory [40].…”
Section: Discussionmentioning
confidence: 99%